NO20090392L - Penem promedikamenter - Google Patents

Penem promedikamenter

Info

Publication number
NO20090392L
NO20090392L NO20090392A NO20090392A NO20090392L NO 20090392 L NO20090392 L NO 20090392L NO 20090392 A NO20090392 A NO 20090392A NO 20090392 A NO20090392 A NO 20090392A NO 20090392 L NO20090392 L NO 20090392L
Authority
NO
Norway
Prior art keywords
penem
promotions
sulopenem
solvates
hydrates
Prior art date
Application number
NO20090392A
Other languages
English (en)
Norwegian (no)
Inventor
Anthony Marfat
Dale Gordon Mcleod
Katherine Elizabeth Brighty
John Paul O'donnell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20090392L publication Critical patent/NO20090392L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20090392A 2006-06-28 2009-01-27 Penem promedikamenter NO20090392L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13
PCT/IB2007/001843 WO2008001212A2 (en) 2006-06-28 2007-06-18 Penem prodrugs

Publications (1)

Publication Number Publication Date
NO20090392L true NO20090392L (no) 2009-01-27

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090392A NO20090392L (no) 2006-06-28 2009-01-27 Penem promedikamenter

Country Status (29)

Country Link
US (2) US7795243B2 (es)
EP (1) EP2044085B1 (es)
JP (2) JP4397435B2 (es)
KR (1) KR101060448B1 (es)
AP (1) AP2008004705A0 (es)
AR (1) AR061646A1 (es)
AT (1) ATE493419T1 (es)
AU (1) AU2007263519B2 (es)
BR (1) BRPI0712740A2 (es)
CA (1) CA2655485C (es)
CL (1) CL2007001910A1 (es)
CR (1) CR10467A (es)
DE (1) DE602007011622D1 (es)
DK (1) DK2044085T3 (es)
EA (1) EA200870584A1 (es)
EC (1) ECSP088947A (es)
GT (1) GT200700050A (es)
HK (1) HK1134928A1 (es)
IL (1) IL195383A0 (es)
MA (1) MA30568B1 (es)
MX (1) MX2009000116A (es)
NL (1) NL2000715C2 (es)
NO (1) NO20090392L (es)
PE (1) PE20080940A1 (es)
SV (1) SV2008003139A (es)
TN (1) TNSN08537A1 (es)
TW (1) TW200816999A (es)
UY (1) UY30439A1 (es)
WO (1) WO2008001212A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (en) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. O-alkylated pi-3 kinase inhibitor prodrug combination
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
JP2013501733A (ja) * 2009-08-10 2013-01-17 ビーエイチアイ リミテッド パートナーシップ 1,3−プロパンジスルホン酸を送達するための方法、化合物、および組成物
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EP3790535A1 (en) 2019-02-13 2021-03-17 Iterum Therapeutics International Limited Combinations of beta-lactam compounds and probenecid and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
US5013729A (en) * 1987-05-11 1991-05-07 Pfizer Inc. Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
GB8713515D0 (en) 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
CA2089366C (en) 1990-08-20 2001-10-16 Hiromitsu Iwata Penem compounds
JP3148235B2 (ja) 1990-08-20 2001-03-19 サントリー株式会社 抗菌性ペネム化合物
WO2004067532A1 (ja) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. 新規カルバペネム誘導体
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
EP2043728A2 (en) * 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
US20090042853A1 (en) 2009-02-12
KR20090015147A (ko) 2009-02-11
PE20080940A1 (es) 2008-07-09
TW200816999A (en) 2008-04-16
CL2007001910A1 (es) 2008-01-11
AU2007263519B2 (en) 2011-05-19
US7795243B2 (en) 2010-09-14
JP5152527B2 (ja) 2013-02-27
CA2655485A1 (en) 2008-01-03
MA30568B1 (fr) 2009-07-01
JP2010013468A (ja) 2010-01-21
UY30439A1 (es) 2008-01-31
ECSP088947A (es) 2009-01-30
SV2008003139A (es) 2010-01-12
BRPI0712740A2 (pt) 2012-06-05
MX2009000116A (es) 2009-01-23
US7795244B2 (en) 2010-09-14
JP4397435B2 (ja) 2010-01-13
NL2000715A1 (nl) 2008-01-02
IL195383A0 (en) 2009-08-03
EP2044085B1 (en) 2010-12-29
EA200870584A1 (ru) 2009-06-30
EP2044085A2 (en) 2009-04-08
JP2009542616A (ja) 2009-12-03
GT200700050A (es) 2008-02-01
NL2000715C2 (nl) 2008-03-11
CA2655485C (en) 2011-08-02
US20080009474A1 (en) 2008-01-10
AU2007263519A1 (en) 2008-01-03
DK2044085T3 (da) 2011-03-07
AP2008004705A0 (en) 2008-12-31
DE602007011622D1 (en) 2011-02-10
ATE493419T1 (de) 2011-01-15
WO2008001212A2 (en) 2008-01-03
AR061646A1 (es) 2008-09-10
CR10467A (es) 2009-01-19
HK1134928A1 (en) 2010-05-20
KR101060448B1 (ko) 2011-08-29
WO2008001212A3 (en) 2008-03-20
TNSN08537A1 (fr) 2010-04-14

Similar Documents

Publication Publication Date Title
NO20090392L (no) Penem promedikamenter
NO20053845L (no) Gyraseinhibitorer og anvendelser derav
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
NO20070866L (no) Antivirale forbindelser.
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
NO20081636L (no) FAP - inhibitorer
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
AU2002327180A1 (en) Detection and therapy of vulnerable plaque with photodynamic compounds
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
TW200738281A (en) Bazedoxifene acetate formulations
DK1789419T3 (da) Gyraseinhibitorer og anvendelser deraf
WO2008076427A3 (en) Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
NO20054945L (no) Orale formulering av cladribin
TW200605863A (en) Bazedoxifene acetate formulations
ATE538084T1 (de) Bicyclische 1,4-retigabin-analoga als kaliumkanalhemmer
NO20060896L (no) Alfa-aminoamidderivater nyttige som antiinflammatoriske midler
ATE375978T1 (de) Benzoylsulfonamide als antitumor-mittel
NO20051168L (no) Anvendelse av fermentert hvetekimekstrakt som anti-inflammasjonsmiddel
SE0103710D0 (sv) Compounds
DK1373220T3 (da) Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion
NO20080839L (no) Isotopsubstituerte protonpumpeinhibitorer
DE60213802D1 (de) Cak inhibitoren und deren verwendungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application